Zydus Lifesciences Limited
ZYDUSLIFE
Kedudukan dalam Saham
#1750
Zydus Lifesciences Limited, an Indian enterprise founded in Ahmedabad in 1952,... Zydus Lifesciences Limited, an Indian enterprise founded in Ahmedabad in 1952, operates globally in the pharmaceutical and consumer goods sectors. Renamed from Cadila Healthcare Limited in February 2022, the company manages the entire lifecycle of pharmaceutical products, from research and development to manufacturing, marketing, and distribution. Its extensive reach covers India, the United States, Europe, Latin America, the Asia Pacific region, and Africa. The company's pharmaceutical division provides a broad spectrum of offerings, including finished dosage human formulations (such as generics, branded generics, and specialized treatments like biosimilars and vaccines), as well as active pharmaceutical ingredients (APIs). Zydus focuses on therapeutic areas like pain management, neurology, dermatology, and liver diseases, among others. Additionally, it is developing a pipeline of biological products aimed at conditions such as oncology, autoimmune disorders, nephrology, ophthalmology, inflammation, rheumatology, hepatology, and infectious diseases. In its consumer products segment, Zydus offers popular wellness brands including Complan, the EverYuth range of skincare products, Nycil, Glucon-D glucose powder, Nutralite, and the Nutralite Doodhshakti dairy product line. Beyond these core operations, the company is also involved in investment activities, animal health and veterinary services, pharmacy retail, and human resource supply and administration.
Harga Saham
$12.30
Modal Pasaran
$12.27B
Perubahan (1 hari)
0.06%
Perubahan (1 tahun)
8.33%
Negara
IN
Perdagangan Zydus Lifesciences Limited (ZYDUSLIFE)
Kategori
Healthcare
Bilangan saham terbitan bagi Zydus Lifesciences Limited (ZYDUSLIFE)
Bilangan saham terbitan setakat June 2026: 1.01B
Menurut laporan kewangan terkini dan harga saham Zydus Lifesciences Limited, bilangan saham terbitan semasa ialah 1.01B. Pada akhir March 2024, syarikat mempunyai 1.01B saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Zydus Lifesciences Limited (ZYDUSLIFE) dari 2004 hingga 2026
Saham terbitan pada akhir setiap tahun
| Tahun | Saham Terbitan | Ubah |
|---|---|---|
| 2026 (TTM) | 1.01B | -0.12% |
| 2025 | 1.01B | -0.55% |
| 2024 | 1.01B | -0.37% |
| 2023 | 1.02B | -0.79% |
| 2022 | 1.02B | 0.00% |
| 2021 | 1.02B | 0.00% |
| 2020 | 1.02B | 0.00% |
| 2019 | 1.02B | 0.00% |
| 2018 | 1.02B | 0.00% |
| 2017 | 1.02B | 0.00% |
| 2016 | 1.02B | 0.00% |
| 2015 | 1.02B | 0.00% |
| 2014 | 1.02B | 0.00% |
| 2013 | 1.02B | 0.00% |
| 2012 | 1.02B | 0.00% |
| 2011 | 1.02B | 0.00% |
| 2010 | 1.02B | 0.00% |
| 2009 | 1.02B | 8.67% |
| 2008 | 942.10M | 0.00% |
| 2007 | 942.10M | 0.00% |
| 2006 | 942.10M | 100.00% |
| 2005 | 471.05M | 0.00% |
| 2004 | 471.05M | 0.00% |
Saham terbitan bagi syarikat atau pesaing yang serupa
| Syarikat | Saham Terbitan | Perbezaan | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 138.71% |
IN
|
